Literature DB >> 7786814

Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer.

Y Yonemura1, I Ninomiya, M Kaji, K Sugiyama, T Fujimura, K Tsuchihara, T Kawamura, I Miyazaki, Y Endou, M Tanaka.   

Abstract

E-cadherin, Ca(2+)-dependent intracellular adhesion molecule, is known to be an invasion suppressor gene. To elucidate the correlation between E-cadherin expression and invasion or metastasis in gastric cancer, we examined E-cadherin tissue status immunohistochemically. Ninety-eight primary gastric cancer, prepared by AMeX method, were retrospectively analyzed with anti-E-cadherin monoclonal antibody. In normal gastric epithelium, E-cadherin is expressed homogeneously with a typical membranous staining at cell-cell borders. Decreased and heterogeneous expression is found in 70 of 98 tumours. Tumours with decreased E-cadherin expression had a tendency to infiltrate more deeply in stomach wall, and metastasize in lymph nodes or peritoneal surface. More importantly, decreased E-cadherin expression correlates with shorter survival (z = 3.98, P = 0.00086). These results may indicate that E-cadherin tissue status is a powerful prognostic indicator in gastric cancer. The high malignant potential of tumours with decreased E-cadherin expression may be associated with high potential of lymph node metastasis and peritoneal dissemination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7786814

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  9 in total

1.  Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma.

Authors:  Zhaode Bu; Zhixue Zheng; Ziyu Li; Xiaojiang Wu; Lianhai Zhang; Aiwen Wu; Xianglong Zong; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

2.  Clinicopathological features of stomach cancer with invasive micropapillary component.

Authors:  Takeo Fujita; Naoto Gotohda; Yuichiro Kato; Takahiro Kinoshita; Shinichiro Takahashi; Masaru Konishi; Hiroyuki Daiko; Mitsuyo Nishimura; Takeshi Kuwata; Atsushi Ochiai; Taira Kinoshita
Journal:  Gastric Cancer       Date:  2011-10-12       Impact factor: 7.370

3.  Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis.

Authors:  Ze-Yu Wu; Wen-Hua Zhan; Jing-Hua Li; Yu-Long He; Jian-Ping Wang; Ping Lan; Jun-Sheng Peng; Shi-Rong Cai
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

4.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation.

Authors:  T Bailey; L Biddlestone; N Shepherd; H Barr; P Warner; J Jankowski
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

5.  The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer.

Authors:  C Xiangming; S Hokita; K Nuruki; H Toyoyama; G Tanabe; M Baba; S Takao; T Aikou
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

6.  Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.

Authors:  S Ramesh; J Nash; P G McCulloch
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

7.  UBE2T knockdown inhibits gastric cancer progression.

Authors:  Changjiang Luo; Yunyi Yao; Zeyuan Yu; Huinian Zhou; Lingyun Guo; Junqiang Zhang; Hongtai Cao; Genyuan Zhang; Yumin Li; Zuoyi Jiao
Journal:  Oncotarget       Date:  2017-05-16

8.  Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.

Authors:  M Anders; M Vieth; C Röcken; M Ebert; M Pross; S Gretschel; P M Schlag; B Wiedenmann; W Kemmner; M Höcker
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

Review 9.  Molecular mediators of peritoneal metastasis in pancreatic cancer.

Authors:  Leela Rani Avula; Brendan Hagerty; Christine Alewine
Journal:  Cancer Metastasis Rev       Date:  2020-08-11       Impact factor: 9.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.